The global wound healing industry was valued at USD 28.9 billion in 2024 and is projected to surpass USD 45.5 billion by the end of 2035, expanding at a CAGR of 4.3% from 2025 to 2035. Market growth is driven by the rising prevalence of chronic wounds, increasing cases of diabetes and obesity, and the growing demand for advanced wound care products. Additionally, technological advancements in...

The global microbiology culture industry was valued at USD 8.8 billion in 2024 and is projected to reach USD 16.4 billion by the end of 2035, expanding at a CAGR of 5.8% from 2025 to 2035. The market growth is driven by increasing demand for microbiological testing in clinical diagnostics, pharmaceutical research, and food safety applications. Rising prevalence of infectious diseases, growing...

The global biologics industry was valued at US$ 448.8 billion in 2024 and is expected to reach US$ 1,140.2 billion by the end of 2035, expanding at a CAGR of 8.8% from 2025 to 2035. The market growth is driven by the increasing demand for targeted therapies, rising prevalence of chronic diseases, and continuous advancements in biotechnology and biopharmaceutical research. Additionally, growing...

The global insulin industry was valued at USD 20.3 billion in 2024 and is projected to surpass USD 31.5 billion by the end of 2035, growing at a CAGR of 4.1% from 2025 to 2035. Market growth is primarily driven by the rising prevalence of diabetes worldwide, increasing demand for advanced insulin therapies, and continuous innovations in insulin delivery systems. Expanding healthcare access and...

The global synthetic biology industry was valued at USD 18.9 billion in 2024 and is expected to reach USD 84.7 billion by 2035, expanding at a CAGR of 14.1% from 2025 to 2035. The market growth is driven by increasing adoption of synthetic biology in healthcare, agriculture, and industrial biotechnology, along with advancements in gene editing, DNA sequencing, and bioengineering technologies....

The global Psoriasis Treatment industry was valued at USD 35.0 Bn in 2024 and is projected to surpass USD 87.6 Bn by the end of 2035, expanding at a CAGR of 9.5% from 2025 to 2035. Growth is driven by the rising prevalence of psoriasis, increasing adoption of biologic therapies, advancements in targeted treatments, and growing awareness of dermatological health. Dive Deeper into Data: Get Your...

The global Addiction Treatment Market was valued at USD 9.8 Bn in 2024 and is projected to reach USD 19.8 Bn by the end of 2035, expanding at a CAGR of 6.6% from 2025 to 2035. Growth is driven by the rising prevalence of substance abuse disorders, increasing awareness of mental health, expanding rehabilitation programs, and the growing adoption of medication-assisted treatment and behavioral...

The global radiopharmaceuticals market was valued at USD 6.6 Bn in 2024 and is projected to reach USD 14.6 Bn by the end of 2035, expanding at a CAGR of 7.6% from 2025 to 2035. Growth is driven by the rising prevalence of cancer and cardiovascular diseases, increasing adoption of nuclear medicine in diagnostic imaging, and ongoing advancements in targeted radiotherapy. The radiopharmaceutical...

The global orthobiologics market was valued at USD 6.8 Bn in 2024 and is projected to reach USD 12.2 Bn by the end of 2035, expanding at a CAGR of 5.5% from 2025 to 2035. Growth is driven by the increasing prevalence of orthopedic disorders, rising sports injuries, and growing adoption of biologic therapies for bone and joint repair. Orthobiologics is a clinical specialty of regenerative...

The global Organoids market was valued at USD 1.1 Bn in 2024 and is projected to surpass USD 4.2 Bn by the end of 2035, expanding at a CAGR of 13.4% from 2025 to 2035. The growth is driven by increasing adoption of organoid models in drug discovery, personalized medicine, and disease modeling, along with rising investments in advanced biomedical research and regenerative medicine. Recent...